54
Referências bibliográficas
Camassola M, Braga L M, Cañedo
A D, Dalberto TP, Matte U, Burin M, Giugliani
R
and Nardi
N B (2005) Nonviral in vivo gene transfer in the mucopolysaccharidosis
I murine model. J Inher Metab Dises, 28:1035-1043.
Connelly S (1999) Adenoviral vectors. In: Meager, A., ed.: Gene Therapy Tecnologies,
Applications and Regulations. From Laboratory to Clinic. New York: John Wiley,
87-107.
Davis SS and Illum L (2003) Absorption enhancers for nasal drug delivery. Clin
Pharmacokinet, 42:1107-1128.
Gardlík R, Pálffy R, Hodosy J, Lukács J, Turma J and Celec P (2005) Vectors and
delivery systems in gene therapy. Med Sci Monit, 11:110-121.
Garrett DL, Larson JE, Dunn D, Luis Marrero L and Cohen JC (2003) In utero
recombinant adeno-associated virus gene transfer in mice,rats, and primates. BMC
Biotechnol, 3:3-16.
Graff CL and Pollack GM (2003) P-Glycoprotein attenuates brain uptake of substrates
after nasal instillation. Pharm Res, 20:1225-30. Pharm Res, 2003 20:1225-1230.
Griesenback U, Cassady RL, Ferrari S, Fukumura M, Müller C, Schmitt E, Zhu J,
Jeffery PK, Nagai Y, Geddes DM, Hasegawa M and Alton EFW (2001) The nasal
epithelium as a factory for systemic protein delivery. Mol Ther, 5: 98-103.
Han, I K, Kim MY, Byun H M, Hwang TS, Kim JM, Hwang KW, Park TG, Jung
WW, Chun T, Jeong GJ and Oh YK (2007) Enhanced brain targeting efficiency of
intranasally administered plasmid DNA: an alternative route for brain gene
therapy. J Mol Med, 85:75-83.
Herweijer H and Wolff JA (2003) Progress and prospects: naked DNA gene transfer